Clinical Stage 1:
Clinical Stage 2:
Clinical Stage 3:
Clinical Stage 4:
Serologic Tests in the Diagnosis of HIV-1 or HIV-2 Infection.
In resource-poor countries, confirming HIV screening test results through PCR or western blot is impractical due to the expense and limited availability of these assays. The National AIDS Control Organization (NACO) in India has devised a strategic plan for HIV diagnosis.
There are four strategic plans/algorithms outlined by NACO:
1. Strategy I:
2. Strategy II (a):
3. Strategy II (b):
4. Strategy III:
Use test of high sensitivity
A blood unit that tests positive should be discarded. In the event that the donor has consented to be notified of their result, it becomes a diagnostic matter, requiring the use of strategies II and III following appropriate counseling. The donor should then be referred to an Integrated Counseling and Testing Center (ICTC) for result confirmation.
Used in Sentinel surveillance
Used for diagnosis in asymptomatic patients
Test 1-High sensitivity Test 2 and 3-High specificity
If results remain negative despite repeated testing, conduct PCR testing (if facilities are available) and refer the case to the National Viral Reference Laboratory (NVRL)
More than 90% of individuals with HIV infection experience dermatologic issues.
Non-Neoplastic:
Neoplastic:
7 videos|219 docs
|
1. What is WHO-HIV clinical staging in adults? |
2. What are the modes of transmission for HIV? |
3. How is HIV diagnosed through serological testing? |
4. What is NACO's testing strategy for HIV diagnosis? |
5. What are the dermatological manifestations of HIV? |
|
Explore Courses for UPSC exam
|